IAG . Bankinter Fija su Precio Objetivo en 3,50€ Por Acción . En Marcha la Recompra de Acciones .
31 agosto 2018
Trabectedin for soft-tissue sarcoma safe, effective in elderly patients .
This subgroup analysis of the elderly population of ET743-SAR-3007 suggests that elderly patients with soft tissue sarcoma and good performance status can expect clinical benefit from trabectedin similar to that observed in younger patients. ...
Entrada más reciente
Entrada antigua
Inicio
Ver versión para móviles